Related Experiment Video
Updated: Apr 17, 2026

Ex Vivo Corneal Organ Culture Model for Wound Healing Studies
Published on: February 15, 2019
Peptide therapies for ocular surface disturbances based on fibronectin-integrin interactions
Teruo Nishida1, Makoto Inui2, Motoyoshi Nomizu3
1Ohshima Hospital of Ophthalmology, 11-8 Kamigofuku, Hakata-ku, Fukuoka 812-0036, Japan; Yamaguchi University, 1-1-1 Minami-kogushi, Ube City, Yamaguchi 755-8505, Japan.
New peptide eyedrops promote corneal epithelial healing by providing a substrate and activating cells, offering a safe treatment for persistent epithelial defects (PEDs). This approach targets the fibronectin-integrin system for enhanced vision restoration.
Area of Science:
- Ophthalmology
- Cell Biology
- Biochemistry
Background:
- The corneal epithelium is vital for vision, and its disorders, like persistent epithelial defects (PEDs), impair corneal transparency.
- Current treatments for corneal epithelial disorders focus on ocular surface protection to facilitate natural healing.
- PEDs are challenging to treat, necessitating novel therapeutic strategies based on understanding their underlying pathobiology.
Purpose of the Study:
- To develop advanced treatments for persistent epithelial defects (PEDs) by leveraging cell and molecular biology insights.
- To investigate the role of fibronectin and growth factors in corneal epithelial wound healing.
- To create peptide-based eyedrops as a safe and effective treatment for PEDs.
Main Methods:
- Characterizing the pathobiology of PEDs at cellular and molecular levels.
- Utilizing fibronectin as a substrate for corneal epithelial cell attachment and migration.
- Activating corneal epithelial cells with substance P and insulin-like growth factor-1 (IGF-1).
- Determining minimal amino acid sequences (PHSRN, FGLM-amide, SSSR) for promoting wound closure.
Main Results:
- Identified the critical role of the fibronectin-integrin system in corneal epithelial wound healing.
- Developed peptide sequences that mimic the function of fibronectin and growth factors.
- Created peptide eyedrops that promote corneal epithelial wound closure effectively.
- Demonstrated that these peptide eyedrops are free from adverse effects associated with parent molecules.
Conclusions:
- Novel peptide eyedrops targeting the fibronectin-integrin pathway offer a promising therapeutic approach for PEDs.
- These peptide-based treatments enhance corneal epithelial healing through cell attachment, migration, and activation.
- The developed peptide eyedrops represent a safe and effective alternative for managing difficult corneal conditions, improving visual outcomes.
Related Concept Videos
Ophthalmic Drug Delivery Systems
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Microbiome of the Eye
Intracellular Signaling Affects Focal Adhesions
Some...

